REPLICATE® System | Updates

By Lea Ellermeier & Rüdger Rubbert

Letter of intent regarding a major contract for the US market entry has been signed


Dear Companists,

Every new investment comment puts a smile on all of our faces. Thank you very much. This is what we intend to achieve for you with our update: We come bearing good news!

The letter of intent regarding a major contract with a volume beyond 15 million euro per year has been signed. With the conclusion of the FDA approval, 300 dentists across the US will start using the REPLICATE System.

Due to non-disclosure agreements we cannot go into details about the deal and the partner company. The cooperating partner is a leading provider of dental services and operates over 150 dental practices. The forthcoming partner of the NDI AG enables an exclusive market access to 300 dentists in one go. A purchase volume of more than 15 million euro for the REPLICATE System has been agreed.


Inspection of a finished REPLICATE tooth


The marketable REPLICATE System has been successfully used for 4 years and has already been granted approval in the EU. With the conclusion of the FDA approval (planned for 2018) the REPLICATE System can get off to an explosive start in the US.

Such major contracts ensure quick market entries with exceptionally high growth potentials in new countries. The cooperation partner has paved the way for NDI to enter the US – the world’s largest homogeneous market for dentistry.

We look forward to capturing the US market together with our Companists.


Kind regards,

Lea and Rüdger


Only registered Companists can comment. Please log in to leave a comment.


Investments in startups and growth companies offer great opportunities, but they are risk investments. In the worst case, the entire investment amount may be lost. Consequently, investments in startups or growth companies are unsuitable for retirement plans. However, there is no obligation to make further contributions. Investors can minimize their risk by diversifying the amount they invest in startups and growth companies and not investing the entire amount in one startup or growth company. Professional investors often follow this strategy because it causes the risk to be distributed among several investments. In this way, successful investments can balance other less successful investments.

The shares of the investors on Companisto are subordinated profit-participating loans (partiarische Nachrangdarlehen). Such loans are shares in a business with similar characteristics as equity. If the company becomes insolvent or is liquidated, the claims of the investors (Companists) – just like those of all other shareholders of the company – will be satisfied from the assets in the insolvency or the assets in liquidation only after the claims of all other external creditors have been satisfied. Thus, Companists are treated like any other shareholder of the company during insolvency or liquidation proceedings.

The company information published on the Companisto website is provided solely by the companies. The projections made by the companies do not guarantee successful development of the company in the future. Consequently, investments in startups and growth companies are suitable only for those investors who can cope with the risk of a total loss of the capital invested. Investors make their own independent investment decisions and bear all risks themselves.

The investments are provided and issued by the individual companies. Companisto is neither the provider nor the issuer of the investments, but solely the internet service platform.

€ 3,500,000

Invested ( € 1M co-invested )

3.23 %

Share Offered

Please note
The acquisition of the offered securities and investments is associated with considerable risks and can lead to the complete loss of the invested assets. The expected yield is not guaranteed and may be lower. Whether it is a security or an asset investment can be seen in the description of the investment opportunity.
Contact Us
If you have any questions about investing on Companisto, please contact our service team:

Toll-free phone number for investors calling from Germany:
0800 - 100 267 0

Companisto investors hotline:
+49(0)30 - 346 491 493

We are available Monday through Friday between 9 a.m. – 6 p.m.

For companies
Apply for financing Investment Model FAQ for Companies
Investor Support
Please register in order to see the complete profile of REPLICATE® System.
Already registered?    Log in